Combination Therapy With Polydeoxyribonucleotide and Pirfenidone Alleviates Symptoms of Acute Respiratory Distress Syndrome in Human Lung Epithelial A549 Cells

키워드

참고문헌 (32)

1. Ranieri VM, "Acute respiratory distress syndrome: the Berlin definition", JAMA, 307, pp.2526~2533 (2012)
2. Gonzales JN, "The acute respiratory distress syndrome: mechanisms and perspective therapeutic approaches", Austin J Vasc Med, 2, pp.1009~ (2015)
3. Johnson ER, "Acute lung injury: epidemiology, patho genesis, and treatment", J Aerosol Med Pulm Drug Deliv, 23, pp.243~252 (2010)
4. Burnham EL, "The fibroproliferative response in acute respiratory distress syndrome:mechanisms and clinical significance", Eur Respir J, 43, pp.276~285 (2014)
5. Cabrera-Benitez NE, "Mechanical ventilation-associated lung fibrosis in acute respiratory distress syndrome: a significant contributor to poor outcome", Anesthesiology, 121, pp.189~198 (2014)
6. Marchioni A, "Acute exacerbation of idiopathic pulmonary fibrosis: lessons learned from acute respiratory distress syndrome?", Crit Care, 22, pp.80~ (2018)
7. Altavilla D, "Polydeoxyribonucleotide (PDRN): a safe approach to induce therapeutic angiogenesis in peripheral artery occlusive disease and in diabetic foot ulcers", Cardiovasc Hematol Agents Med Chem, 7, pp.313~321 (2009)
8. 전정원, "Adenosine A2A-receptor agonist polydeoxyribonucleotide promotes gastric ulcer healing in Mongolian gerbils", Animal Cells and Systems, 18(6), pp.399~406 (2014), 한국통합생물학회[DOI]
9. Bitto A, "Polydeoxyribonucleotide reduces cytokine production and the severity of collagen-induced arthritis by stimulation of adenosine A2A receptor", Arthritis Rheum, 63, pp.3364~3371 (2011)
10. Ko IG, "Combination therapy with polydeoxyribonucleotide and proton pump inhibitor enhances therapeutic effectiveness for gastric ulcer in rats", Life Sci, 203, pp.12~19 (2018)
11. An J, "Polydeoxyribonucleotide ameliorates lipopolysaccharide-induced lung injury by inhibiting apoptotic cell death in rats", Int J Mol Sci, 18, pp.E1847~ (2017)
12. Margaritopoulos GA, "Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapy", Core Evid, 11, pp.11~22 (2016)
13. Kakugawa T, "Pirfenidone attenuates expression of HSP47 in murine bleomycin-induced pulmonary fibrosis", Eur Respir J, 24, pp.57~65 (2004)
14. Schaefer CJ, "Antifibrotic activities of pirfenidone in animal models", Eur Respir Rev, 20, pp.85~97 (2011)
15. 정형모, "Effect of Polydeoxyribonucleotide on Lipopolysaccharide and Sevoflurane-Induced Postoperative Cognitive Dysfunction in Human Neuronal SH-SY5Y Cells", International Neurourology Journal, 23, pp.93~101 (2019), 대한배뇨장애요실금학회[DOI]
16. 김이화, "Antioxidative and anti-inflammatory effect of Phellinus igniarius on RAW 264.7 macrophage cells", Journal of exercise rehabilitation, 15(1), pp.2~7 (2019), 한국운동재활학회[DOI]
17. 김이화, "Effect of type II collagen extract on immunosuppression induced by methotrexate in rats", Journal of exercise rehabilitation, 14(5), pp.731~738 (2018), 한국운동재활학회
18. 진찬호, "The effects of combined aerobic and resistance training on inflammatory markers in obese men", Journal of exercise rehabilitation, 14(4), pp.660~665 (2018), 한국운동재활학회
19. 이삼준, "Effects of preconditioning exercise on nitric oxide and antioxidants in hippocampus of epileptic seizure", Journal of exercise rehabilitation, 15(6), pp.757~762 (2019), 한국운동재활학회[DOI]
20. Wilson KC, "Acute respiratory failure from abused substances", J Intensive Care Med, 19, pp.183~193 (2004)
21. Molina-Molina M, "Anti-fibrotic effects of pirfenidone and rapamycin in primary IPF fibroblasts and human alveolar epithelial cells", BMC Pulm Med, 18, pp.63~ (2018)
22. Odashima M, "Attenuation of gastric mucosal inflammation induced by aspirin through activation of A2A adenosine receptor in rats", World J Gastroenterol, 12, pp.568~573 (2006)
23. Haskó G, "Adenosine receptors:therapeutic aspects for inflammatory and immune diseases", Nat Rev Drug Discov, 7, pp.759~770 (2008)
24. Milne GR, "Anti-inflammatory and immunosuppressive effects of the A2A adenosine receptor", ScientificWorldJournal, 11, pp.320~339 (2011)
25. Zhou WQ, "Lipopolysaccharide promotes pulmonary fibrosis in acute respiratory distress syndrome (ARDS)via lincRNA-p21 induced inhibition of Thy-1 expression", Mol Cell Biochem, 419, pp.19~28 (2016)
26. Willis BC, "TGF-β-induced EMT: mechanisms and implications for fibrotic lung disease", Am J Physiol Lung Cell Mol Physiol, 293, pp.L525~L534 (2007)
27. Chambers RC, "Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention?", Br J Pharmacol, 153, pp.S367~S378 (2008)
28. Lundblad LK, "Tumor necrosis factor-α overexpression in lung disease: a single cause behind a complex phenotype", Am J Respir Crit Care Med, 171, pp.1363~1370 (2005)
29. Pooladanda V, "Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-α mediated NF-κB and HDAC-3 nuclear translocation", Cell Death Dis, 10, pp.81~ (2019)
30. 박상서, "Treadmill Exercise Ameliorates Chemotherapy-Induced Muscle Weakness and Central Fatigue by Enhancing Mitochondrial Function and Inhibiting Apoptosis", International Neurourology Journal, 23, pp.32~39 (2019), 대한배뇨장애요실금학회[DOI]
31. Nakazato H, "A novel antifibrotic agent pirfenidone suppresses tumor necrosis factor-α at the translational level", Eur J Pharmacol, 446, pp.177~185 (2002)
32. Hale ML, "Pirfenidone blocks the in vitro and in vivo effects of staphylococcal enterotoxin B", Infect Immun, 70, pp.2989~2994 (2002)

관련 논문AI추천